Bill
S 2374
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
2026-2027 Regular Session
Introduced by Jon Bramnick and 1 co-sponsor
New Jersey bill eliminates insurance pre-approval requirements for cancer treatments and drugs, enabling immediate access but potentially raising premiums and allowing denied claims post-treatment.
Introduced in the Senate, Referred to Senate Commerce Committee